MAPT and Alzheimer disease: Hypercholesterolemia and the disruption of cholesterol metabolism play an important role in the pathology of AD, affecting Aβ formation, hyperphosphorylation of tau protein, disruption of cholinergic signaling, and neuroinflammation [63].